Literature DB >> 29451661

Association between the RAGE (receptor for advanced glycation end-products) -374T/A gene polymorphism and diabetic retinopathy in T2DM.

Dan Tao1,2, Xuancheng Mai3, Tiesong Zhang2, Yan Mei3,4.   

Abstract

OBJECTIVE: Interaction between advanced glycation end-products (AGEs) and receptor for AGEs (RAGE) in cells could affect both extracellular and intracellular structure and function, which plays a pivotal role in diabetic microvascular complications. The results from previous epidemiological studies on the association between RAGE gene -374T/A polymorphism and diabetic retinopathy (DR) risk were inconsistent. Thus, we conducted this meta-analysis to summarize the possible association between RAGE -374T/A polymorphism and DR risk.
METHOD: We searched all relevant articles on the association between RAGE -374T/A polymorphism and DR risk from PubMed, Cochrane Library, ScienceDirect, Wanfang, VIP and Chinese National Knowledge Infrastructure (CNKI) web databases up to August 2016. Odds ratio (OR) with 95% confidence interval (CI) were calculated to assess those associations. All analyses were performed using the Review Manager software.
RESULTS: Nine case-control studies, including 1,705 DR cases and 2,236 controls were enrolled, and the results showed that the A allele of RAGE -374T/A polymorphism was significantly associated with increased DR risk in dominant model (TA/AA vs. TT: OR=1.22, 95CI 1.05-1.41, p=0.006) and heterozygote model (TA vs. TT: OR=1.26, 95CI 1.07-1.47, p=0.005). The subgroup analysis by ethnicity showed that significantly increased DR risk was found in both Asian and Caucasian populations.
CONCLUSION: This meta-analysis reveals that the A allele of RAGE -374T/A polymorphism probably increase DR risk.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29451661     DOI: 10.1590/1806-9282.63.11.971

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  5 in total

Review 1.  Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World.

Authors:  Ashay D Bhatwadekar; Aumer Shughoury; Ameya Belamkar; Thomas A Ciulla
Journal:  Genes (Basel)       Date:  2021-07-31       Impact factor: 4.141

2.  Association analysis of 374T/A (rs1800624) receptor for advanced glycation end-products (RAGE) gene polymorphism with diabetic retinopathy in Pakistani patients.

Authors:  Shazia Qayyum; Muhammad Afzal; Abdul Khaliq Naveed
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

Review 3.  Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology.

Authors:  Olvera-Montaño Cecilia; Castellanos-González José Alberto; Navarro-Partida José; Cardona-Muñoz Ernesto Germán; López-Contreras Ana Karen; Roman-Pintos Luis Miguel; Robles-Rivera Ricardo Raúl; Rodríguez-Carrizalez Adolfo Daniel
Journal:  J Diabetes Res       Date:  2019-08-14       Impact factor: 4.011

4.  Dysregulation of Receptor for Advanced Glycation End Products (RAGE) Expression as a Biomarker of Keratoconus.

Authors:  Valentin Navel; Jean Malecaze; Corinne Belville; Héléna Choltus; Fanny Henrioux; Frédéric Dutheil; François Malecaze; Frédéric Chiambaretta; Loïc Blanchon; Vincent Sapin
Journal:  Dis Markers       Date:  2022-01-15       Impact factor: 3.434

Review 5.  Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications.

Authors:  Misganaw Asmamaw Mengstie; Endeshaw Chekol Abebe; Awgichew Behaile Teklemariam; Anemut Tilahun Mulu; Melaku Mekonnen Agidew; Muluken Teshome Azezew; Edgeit Abebe Zewde; Assefa Agegnehu Teshome
Journal:  Front Mol Biosci       Date:  2022-09-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.